1、 蒲秀红, 邱萌, 郭晓清,等. 高胆红素血症新生儿碳氧血红蛋白检测的意义[J]. 中华实用儿科临床杂志, 2006,21(20):1411-1412. 蒲秀红, 邱萌, 郭晓清,等. 高胆红素血症新生儿碳氧血红蛋白检测的意义[J]. 中华实用儿科临床杂志, 2006,21(20):1411-1412.
2、 SCHUTZMAN D L, GATIEN E, AJAYI S, et al. Carboxyhemoglobin levels as a predictor of risk for significant hyperbilirubinemia in African-American DAT+ infants[J]. J Perinatol, 2016, 36(5):386-388. SCHUTZMAN D L, GATIEN E, AJAYI S, et al. Carboxyhemoglobin levels as a predictor of risk for significant hyperbilirubinemia in African-American DAT+ infants[J]. J Perinatol, 2016, 36(5):386-388.
3、 LOZAR-KRIVEC J, BRATANIC B, PARO-PANJAN D. The role of carboxyhemoglobin measured with CO-oximetry in the detection of hemolysis in newborns with ABO alloimmunization[J]. J Matern Fetal Med, 2016,29(3):452-456. LOZAR-KRIVEC J, BRATANIC B, PARO-PANJAN D. The role of carboxyhemoglobin measured with CO-oximetry in the detection of hemolysis in newborns with ABO alloimmunization[J]. J Matern Fetal Med, 2016,29(3):452-456.
4、 BHUTANI V K, SRINIVAS S, CASTILLO CUADRADO M E, et al. Identification of neonatal haemolysis: an approach to predischarge management of neonatal hyperbilirubinemia[J]. Acta Paediatrica, 2016, 105(5):e189-e194. BHUTANI V K, SRINIVAS S, CASTILLO CUADRADO M E, et al. Identification of neonatal haemolysis: an approach to predischarge management of neonatal hyperbilirubinemia[J]. Acta Paediatrica, 2016, 105(5):e189-e194.
5、 CHRISTENSEN R D, MALLESKE D T, LAMBERT D K, et al. Measuring end-tidal carbon monoxide of jaundiced neonates in the birth hospital to identify those with hemolysis[J]. Neonatol, 2015, 109(1):1-5. CHRISTENSEN R D, MALLESKE D T, LAMBERT D K, et al. Measuring end-tidal carbon monoxide of jaundiced neonates in the birth hospital to identify those with hemolysis[J]. Neonatol, 2015, 109(1):1-5.
6、 CHRISTENSEN R D, LAMBERT D K, HENRY E, et al. End-tidal carbon monoxide as an indicator of the hemolytic rate[J]. Blood Cell Mol Dis, 2015, 54(3):292-296. CHRISTENSEN R D, LAMBERT D K, HENRY E, et al. End-tidal carbon monoxide as an indicator of the hemolytic rate[J]. Blood Cell Mol Dis, 2015, 54(3):292-296.
7、 BHUTANI V K, WONG R J, VREMAN H J, et al. Bilirubin production and hour-specific bilirubin levels[J]. J Perinatol, 2015 (35):735-738. BHUTANI V K, WONG R J, VREMAN H J, et al. Bilirubin production and hour-specific bilirubin levels[J]. J Perinatol, 2015 (35):735-738.
8、 VALSAMI S, POLITOU M, BOUTSIKOU Τ, et al. Importance of direct antiglobulin test (dat) in cord blood: causes of dat (+) in a cohort study[J]. Pediatr Neonatol, 2015, 56(4):256-260. VALSAMI S, POLITOU M, BOUTSIKOU Τ, et al. Importance of direct antiglobulin test (dat) in cord blood: causes of dat (+) in a cohort study[J]. Pediatr Neonatol, 2015, 56(4):256-260.
9、 KRISTINSDOTTIR T, KJARTANSSON S, HARDARDOTTIR H, et al. Positive coomb's test in newborns; causes and clinical consequences summary of cases diagnosed in the blood bank in the years 2005 to 2012[J]. L?knabla?i?, 2016, 102(7):326. KRISTINSDOTTIR T, KJARTANSSON S, HARDARDOTTIR H, et al. Positive coomb's test in newborns; causes and clinical consequences summary of cases diagnosed in the blood bank in the years 2005 to 2012[J]. L?knabla?i?, 2016, 102(7):326.
10、 HAKAN N, ZNCIROGLU A, AYDIN M, et al. Exchange transfusion for neonatal hyperbilirubinemia: an 8-year single center experience at a tertiary neonatal intensive care unit in turkey[J]. J Matern Fetal Med, 2014, 28(13):1537-1541. HAKAN N, ZNCIROGLU A, AYDIN M, et al. Exchange transfusion for neonatal hyperbilirubinemia: an 8-year single center experience at a tertiary neonatal intensive care unit in turkey[J]. J Matern Fetal Med, 2014, 28(13):1537-1541.
11、 JALLOH S, ROSTENBERGHE H V, YUSOFF N M, et al. Poor correlation between hemolysis and jaundice in glucose 6-phosphate dehydrogenase-deficient babies[J]. Pediatr Int, 2010,47(3):258-261. JALLOH S, ROSTENBERGHE H V, YUSOFF N M, et al. Poor correlation between hemolysis and jaundice in glucose 6-phosphate dehydrogenase-deficient babies[J]. Pediatr Int, 2010,47(3):258-261.
12、 CHRISTENSEN R D, BAER V L, MACQUEEN B C, et al. ABO hemolytic disease of the fetus and newborn: thirteen years of data after implementing a universal bilirubin screening and management program[J]. J Perinatol, 2018,38(2):517-525. CHRISTENSEN R D, BAER V L, MACQUEEN B C, et al. ABO hemolytic disease of the fetus and newborn: thirteen years of data after implementing a universal bilirubin screening and management program[J]. J Perinatol, 2018,38(2):517-525.
13、 施丽, 田雪梅, 何明. 伊犁地区1 034例新生儿溶血病的实验室检测结果分析[J]. 中国输血杂志, 2015,28(3):289-291. 施丽, 田雪梅, 何明. 伊犁地区1 034例新生儿溶血病的实验室检测结果分析[J]. 中国输血杂志, 2015,28(3):289-291.
14、 SCRAFFORD C G, MULLANY L C, KATZ J, et al. Incidence of and risk factors for neonatal jaundice among newborns in southern Nepal[J]. Trop Med Int Health, 2013, 18(11):1317-1328. SCRAFFORD C G, MULLANY L C, KATZ J, et al. Incidence of and risk factors for neonatal jaundice among newborns in southern Nepal[J]. Trop Med Int Health, 2013, 18(11):1317-1328.
15、 MOJTAHEDI S Y, IZADI A, SEIRAFI G, et al. Risk factors associated with neonatal jaundice: a cross-sectional study from iran[J]. Open Access Maced J Med Sci, 2018, 6(8):1387-1393. MOJTAHEDI S Y, IZADI A, SEIRAFI G, et al. Risk factors associated with neonatal jaundice: a cross-sectional study from iran[J]. Open Access Maced J Med Sci, 2018, 6(8):1387-1393.
